We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPGI
1276
GPGI Inc
GPGI
$4.11B
| $150K | ﹤0.01% |
36,776
-5,117
| -12% | -$21.3K |
|
1277
AMC Entertainment Holdings
AMC
$2.14B
| $139K | ﹤0.01% |
+3,423
| New | +$216K |
|
1278
Sportradar
SRAD
$3.93B
| $139K | ﹤0.01% |
+13,920
| New | +$136K |
|
1279
Future Fuel
FF
$279M
| $135K | ﹤0.01% |
+16,633
| New | +$126K |
|
1280
Manitowoc
MTW
$702M
| $131K | ﹤0.01% |
+14,253
| New | +$130K |
|
1281
Garrett Motion
GTX
$5.43B
| $129K | ﹤0.01% |
+16,913
| New | +$119K |
|
|
OLPX
1282
DELISTED
Olaplex Holdings
OLPX
| $127K | ﹤0.01% |
+24,401
| New | +$145K |
|
1283
Mitek Systems
MITK
$836M
| $126K | ﹤0.01% |
13,013
-6,488
| -33% | -$68.3K |
|
1284
Janus International
JBI
$690M
| $125K | ﹤0.01% |
+13,136
| New | +$127K |
|
|
BCOV
1285
DELISTED
Brightcove, Inc.
BCOV
| $124K | ﹤0.01% |
23,725
-50,755
| -68% | -$296K |
|
1286
Astronics
ATRO
$3.7B
| $120K | ﹤0.01% |
13,985
-22,938
| -62% | -$170K |
|
|
CANG
1287
Cango Inc
CANG
$70.6M
| $108K | ﹤0.01% |
8,259
| – | – |
|
1288
ThredUp
TDUP
$412M
| $106K | ﹤0.01% |
+80,815
| New | +$111K |
|
|
CTG
1289
DELISTED
Computer Task Group, Inc.
CTG
| $103K | ﹤0.01% |
13,680
| – | – |
|
|
RTL
1290
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $102K | ﹤0.01% |
17,245
-222,291
| -93% | -$1.41M |
|
|
USER
1291
DELISTED
UserTesting, Inc.
USER
| $102K | ﹤0.01% |
+13,532
| New | +$86.6K |
|
1292
Mistras Group
MG
$592M
| $101K | ﹤0.01% |
20,477
-6,270
| -23% | -$28.4K |
|
|
NBIS
1293
Nebius Group N.V.
NBIS
$49.1B
| $98K | ﹤0.01% |
32,887
| – | – |
|
1294
Kodiak Sciences
KOD
$2.64B
| $90K | ﹤0.01% |
+12,501
| New | +$89.7K |
|
|
PSTX
1295
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $85K | ﹤0.01% |
15,975
| – | – |
|
1296
Culp Inc
CULP
$43.7M
| $84K | ﹤0.01% |
18,363
-3,019
| -14% | -$14.3K |
|
1297
Kinross Gold
KGC
$32.3B
| $81K | ﹤0.01% |
+19,800
| New | +$78.3K |
|
|
RDNW
1298
RideNow Group
RDNW
$251M
| $80K | ﹤0.01% |
12,381
-49,146
| -80% | -$532K |
|
1299
Relmada Therapeutics
RLMD
$477M
| $75K | ﹤0.01% |
+21,420
| New | +$188K |
|
1300
Mizuho Financial
MFG
$127B
| $71K | ﹤0.01% |
+24,936
| New | +$58.8K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.